Patents by Inventor Patrick KAISER

Patrick KAISER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260286407
    Abstract: The present invention is concerned with the in vivo production of tulipalin A (?-methylene-?-butyrolactone). Provided are methods for the in vivo production of tulipalin A, recombinant cells or organisms for in vivo production of tulipalin A, enzymes needed for the in vivo production of tulipalin A, and nucleic acids for expression of those enzymes.
    Type: Application
    Filed: April 3, 2024
    Publication date: September 24, 2026
    Inventors: Srividhya SUNDARAM, Barbara NAVÉ, Tobias ERB, Joeline XIBERRAS, Birgit HOFF, Oskar ZELDER, Patrick KAISER, Ingeborg HEUSCHKEL, Robin MACK, Philipp WICHMANN, Patrick GERLINGER
  • Patent number: 9919029
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial infections. In particular, the present invention relates to a Toll-like receptor (TLR) agonist for use in a method for the treatment of a bacterial infection in a subject in need thereof wherein the TLR agonist is administered to the subject in combination with at least one antibiotic.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: March 20, 2018
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Universite de Droit et de la Sante de Lille 2, Centre National de la Recherche Scientifique (CNRS), Institut Pasteur de Lille, Universite de Lille 1 Sciences et Technologies, ETH Zurich, Universidad de la Republica
    Inventors: Wolf-Dietrich Hardt, Patrick Kaiser, Jean-Claude Sirard, Christophe Carnoy, Delphine Fougeron, Jose Alejandro Chabalgoity, Natalia Munoz
  • Publication number: 20160151453
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial infections. In particular, the present invention relates to a Toll-like receptor (TLR) agonist for use in a method for the treatment of a bacterial infection in a subject in need thereof wherein the TLR agonist is administered to the subject in combination with at least one antibiotic.
    Type: Application
    Filed: July 25, 2014
    Publication date: June 2, 2016
    Inventors: Wolf-Dietrich HARDT, Patrick KAISER, Jean-Claude SIRARD, Christophe CARNOY, Delphine FOUGERON, Jose Alejandro CHABALGOITY, Natalia MUNOZ